–(BUSINESS WIRE)–New Directions Technology Consulting, LLC:
Napoleon Monroe, managing director, NewDirections Technology Consulting (New Directions), theinventor of five U.S. patents with granted medicationtelemanagement claims. New Directions is the exclusive marketdeveloper of these patents, included in the mMed patent portfolio.
The Drug Delivery Partnerships 2017 conference, Feb. 7-9, 2017
Monroe will make twopresentations:
A. February 7, 2:15pm-2:30pm
Track A presentation: “The Roles of Connected Combination Productsin the Creative Reconstruction of Pharma” will:
• Highlight how connected products can assist in building productand corporate value
• Address some of the issues that have delayed progress
• Discuss some latest developments
B. February 8, 2:15pm-5:00pm
Track 3 intro and panel moderation: Smart & Novel Drug DeliveryTechnology
PGA National Resort & Spa
400 Avenue of the Champions
Palm Beach Gardens, FL 33418
The point of care for drug treatment is wherever the patient doses.Improving medication adherence/compliance can improve outcomes andhelp to reduce the cost of healthcare. Medication telemanagement andformulation innovation also can provide great business opportunitiesfor healthcare stakeholder partnerships, particularly at a time whenstakeholders are being asked to demonstrate evidence-based outcomesand improve quality of life. With mobility being crucial to qualityof life, there is a strong rationale for a Pharma emphasis onmedication telemanagement. Service beyond the script is now animportant part of strategies to gain and retain patients/customers.
New Directions media contact: Rick Sacks, firstname.lastname@example.org,+1 973 467 8728
Conference contact: Paige Santillo, email@example.com,+1 646 895 7484
Note: mMed is a trademark of New Directions TechnologyConsulting, LLC.
For all other news on the health